Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model
Jae-Jin Song, … , C. Justin Lee, Sang-Hun Lee
Jae-Jin Song, … , C. Justin Lee, Sang-Hun Lee
Published December 11, 2017
Citation Information: J Clin Invest. 2018;128(1):e93924. https://doi.org/10.1172/JCI93924.
View: Text | PDF
Research Article Neuroscience

Cografting astrocytes improves cell therapeutic outcomes in a Parkinson’s disease model

  • Text
  • PDF
Abstract

Transplantation of neural progenitor cells (NPCs) is a potential therapy for treating neurodegenerative disorders, but this approach has faced many challenges and limited success, primarily because of inhospitable host brain environments that interfere with enriched neuron engraftment and function. Astrocytes play neurotrophic roles in the developing and adult brain, making them potential candidates for helping with modification of hostile brain environments. In this study, we examined whether astrocytic function could be utilized to overcome the current limitations of cell-based therapies in a murine model of Parkinson’s disease (PD) that is characterized by dopamine (DA) neuron degeneration in the midbrain. We show here that cografting astrocytes, especially those derived from the midbrain, remarkably enhanced NPC-based cell therapeutic outcomes along with robust DA neuron engraftment in PD rats for at least 6 months after transplantation. We further show that engineering of donor astrocytes with Nurr1 and Foxa2, transcription factors that were recently reported to polarize harmful immunogenic glia into the neuroprotective form, further promoted the neurotrophic actions of grafted astrocytes in the cell therapeutic approach. Collectively, these findings suggest that cografting astrocytes could be a potential strategy for successful cell therapeutic outcomes in neurodegenerative disorders.

Authors

Jae-Jin Song, Sang-Min Oh, Oh-Chan Kwon, Noviana Wulansari, Hyun-Seob Lee, Mi-Yoon Chang, Eunsoo Lee, Woong Sun, Sang-Eun Lee, Sunghoe Chang, Heeyoung An, C. Justin Lee, Sang-Hun Lee

×

Figure 3

Paracrine manner of the astrocyte-mediated neurotrophic actions.

Options: View larger image (or click on image) Download as PowerPoint
Paracrine manner of the astrocyte-mediated neurotrophic actions.
(A) Sch...
(A) Schematic of the CM treatment experiments. Media conditioned in Ctx- or VM-Ast (or Ctx-NPC as control) was collected and added to cultured VM-NPCs during the differentiation period. (B) Representative images for TH+ DA neurons at D12. Scale bar: 100 μm. Insets, enlarged images of the boxed areas (original magnification, ×400). (C) TH+DA neuronal yields at D6. *P < 0.05, significantly different from control. n = 3 cultures for each group. (D and E) Morphometric measurement of neurite outgrowth assessed by a time-lapse imaging system. VM-NPCs at D3 were treated with the CMs. Neurite lengths (D) and branch points of the neurites (E) in 27 randomly selected microscopic fields from 3 independent cultures were automatically analyzed for 42 hours using IncuCyte’s NeuroTrack software. (F–J) Expression of mature neuronal (NeuN) and mDA neuronal (Foxa2, Nurr1) markers in the differentiated DA neurons. I and J depict percentage of TH+ cells expressing the markers and the expression levels (MFI) in individual TH+ DA neurons, respectively. *P < 0.01, significantly different from control; #P < 0.01, significantly different from Ctx-Ast, 1-way ANOVA. n = 9 microscopic fields (I) and n = 32–36 TH+ cells (J). (K–M) Resistance of DA neurons against a toxic stimulus. TH+ DA neurons differentiated in the presence of Ctx- or VM-Ast-CM (Ctx-NPC-CM as the control) at D12 were exposed to H2O2 (1,000 μM) for 8 hours and viable TH+ cells were counted on the following day (L). Shown in K are representative TH+ cell images after H2O2 treatment. Scale bars: 100 μm. Insets, high-powered images of the boxed areas (original magnification, ×400). Fiber lengths of surviving TH+ cells were also estimated (M). *P < 0.01; #P < 0.01, 1-way ANOVA. n = 3 independent experiments (2–3 wells/experiment) (L) and n = 80–90 TH+ cells (M). (N) Expression of neurotrophic genes in the cultured Ctx-Ast, VM-Ast, and Ctx-NPCs, estimated by real-time PCR (qPCR) analyses. *P < 0.01; #P < 0.05, 1-way ANOVA. n = 3.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts